Your browser doesn't support javascript.
loading
Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada.
Anderson, Kelly K; Rodrigues, Rebecca; Le, Britney; Mamun, Maliha; Archie, Suzanne; Edwards, Jordan; Elton-Marshall, Tara; Gilliland, Jason; Myran, Daniel Thomas; Palaniyappan, Lena; Perlman, Christopher M; Seabrook, Jamie A; Murray, Robin M; Shariff, Salimah Z.
Affiliation
  • Anderson KK; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London ON Canada; Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London ON Canada; ICES Western, London ON Canada; Lawson Health Research Institute,
  • Rodrigues R; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London ON Canada.
  • Le B; ICES Western, London ON Canada.
  • Mamun M; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London ON Canada.
  • Archie S; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton ON Canada.
  • Edwards J; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton ON Canada.
  • Elton-Marshall T; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London ON Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa ON Canada; Institute of Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto
  • Gilliland J; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London ON Canada; Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University, London ON Canada; Department of Geography and Environment, Western University, Londo
  • Myran DT; Department of Family Medicine, University of Ottawa, Ottawa ON Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa ON Canada; ICES uOttawa, Ottawa Hospital Research Institute, Ottawa ON Canada.
  • Palaniyappan L; Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London ON Canada; Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal ON Canada.
  • Perlman CM; School of Public Health Sciences, University of Waterloo, Waterloo ON Canada.
  • Seabrook JA; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London ON Canada; Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University, London ON Canada; School of Food and Nutritional Sciences, Brescia University Colleg
  • Murray RM; Institute of Psychiatry, Psychology, and Neuroscience, King's College London, United Kingdom.
  • Shariff SZ; Arthur Labatt Family School of Nursing, Western University, London ON Canada; ICES Western, London ON Canada; Lawson Health Research Institute, London Health Sciences Centre, London ON Canada.
Int J Drug Policy ; 123: 104285, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38071933
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Database: MEDLINE Main subject: Psychotic Disorders / Cannabis / Hallucinogens Limits: Humans Country/Region as subject: America do norte Language: En Journal: Int J Drug Policy Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Database: MEDLINE Main subject: Psychotic Disorders / Cannabis / Hallucinogens Limits: Humans Country/Region as subject: America do norte Language: En Journal: Int J Drug Policy Year: 2024 Document type: Article